News

New report shows that some premiums and deductibles were lower for 2019-and that members are using new tools to help them save.

How FDA Chief Gottlieb’s resignation could impact the pharma industry.

Innovation doesn’t happen by accident-here’s how healthcare organizations around the country are bringing their operations and technologies into the future.

Patient identification is in desperate need of an overhaul-and biometrics could be the answer.

No longer a pipe-dream of fringe policy makers, Medicare for All is gaining serious support-and criticism. Here’s what you need to know about the current conversation.

How are employers coping with rising healthcare costs?

Last year brought a variety of new treatments-and complications-for patients and payers. These five areas that defined 2018 will continue to define the future.

Each hospital and health system-and insurer-has unique circumstances, but there are several common approaches that are likely to help curb the growth in drug costs.

The recalls of a widely used hypertension blood drug due to carcinogenic impurities are expanding.

The technology is improving rapidly, becoming not only more accessible but much, much cheaper.

Elodia Mercier, a 34-year nursing veteran, sets the tone for the way patients should be treated.

The latest in RA therapies, and what you can expect from the pipeline.

Managed Healthcare Executive asked top experts their predictions for the top game-changing therapies. Here’s what they said.

FDA is warning about an increased risk of death and blood clots in the lungs in patients with rheumatoid arthritis taking a specific dosage of this drug.

Managed Healthcare Executive asked key opinion leaders “What is the one book healthcare executives should read this year?” Here are their selections.

A new report from Humana shows the benefits of value-based care for patients and providers.

Here’s five things to take away from Anthem’s launch of PBM IngenioRx.

Many patients who were prescribed fentanyl should not have received the drug, a new study said.

FDA is requiring the addition of a Black Box Warning to a gout drug that has an increased risk of death.

HCCI Releases 2017 Health Care Cost and Utilization Report. Here are the revealing findings.

A new study suggests that the FDA and manufacturers did not act when evidence emerged that potentially lethal fentanyl products were being inappropriately prescribed to patients.

Loneliness leads to more healthcare utilization and decreases the likelihood of a positive health outcome post-hospital discharge-but it is underappreciated and rarely well addressed by the healthcare community.

Read the supplement here.

FDA approved first interoperable insulin pump, as well as the only FDA-approved drug for patients with a neglected tropical disease.

We asked healthcare industry leaders to tell us about how their organizations are using technology-from big data to remote monitoring devices. Here’s what they said.

A southern California health system asked its in-hospital physician groups to contract with its insurance carriers. Here’s what happened.